Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Vicarious Surgical ( (RBOT) ).
On January 17, 2025, Vicarious Surgical Inc. announced a consulting agreement with William Kelly following his departure as CFO. Mr. Kelly will provide advisory services until December 31, 2028, with compensation structured monthly and hourly, and his stock options will continue to vest until mid-2025, ensuring a smooth transition and maintaining company stability.
More about Vicarious Surgical
Vicarious Surgical Inc. operates in the medical technology industry, focusing on developing innovative robotic systems for minimally invasive surgery.
YTD Price Performance: 14.52%
Average Trading Volume: 42,392
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $93.65M
See more data about RBOT stock on TipRanks’ Stock Analysis page.
